Pharmaron Beijing Co., Ltd. (HKG:3759)
Hong Kong
· Delayed Price · Currency is HKD 15.40
-0.36 (-2.28%)
Jun 6, 2025, 4:08 PM HKT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Laboratory Services | 6.66B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Laboratory Services Growth | 6.65% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Chemical and Formulation Process Development and Production Services | 2.71B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Chemical and Formulation Process Development and Production Services Growth | 12.64% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Research Services | 1.74B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Research Services Growth | 24.66% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Macromolecule and Cell and Gene Therapy Services | 424.94M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Macromolecule and Cell and Gene Therapy Services Growth | 117.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 4.61M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -82.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 4.61M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -82.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Other | 48.87M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 95.40% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America | 7.40B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | 11.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 1.97B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 5.02% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 1.84B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 24.35% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia (Excluding Mainland China) | 269.04M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia (Excluding Mainland China) Growth | 15.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 48.87M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 95.40% |
Log In |
Log In |
Log In |
Log In | Upgrade
|